Why is hepatitis B still a global threat despite decades of vaccine availability? The answer lies in unequal access, evolving virus strains, and healthcare gaps. But a major shift is now underway—thanks to aggressive immunization drives, digital tracking, and biotech innovation, the fight against hepatitis B is regaining momentum. The Hepatitis B Vaccine Market is seeing renewed growth as...

For years, hepatitis B has been a silent threat—often overlooked but dangerously persistent. Affecting more than 250 million people worldwide, this viral infection targets the liver and can lead to cirrhosis, liver failure, and even cancer. While it’s preventable through vaccination, the fight against this disease is far from over. And now, a global wave of awareness, policy...